Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

UV Disinfection

March 24, 2011 12:20 pm | Product Releases | Comments

Providing chemical-free disinfection for low flow pharmaceutical and biotech applications, Aquionics offers the PharmaLine PQ UV disinfection system. PharmaLine PQ uses USEPA approved UV lamps to destroy pathogens without chemicals.

TOPICS:

Field Verification Service

March 24, 2011 12:18 pm | Product Releases | Comments

Hamilton Robotics introduces Field Verification II, an expanded service that verifies the performance of MICROLAB STAR automated pipetting workstations and peripherals in accordance with GLP/GMP standards.

TOPICS:

CPEX Shareholders Vote for Sale

March 24, 2011 12:14 pm | News | Comments

Specialty drug company CPEX Pharmaceuticals Inc. said that its shareholders voted for the $76.6 million buyout by the holding company Footstar Corp.

TOPICS:
Advertisement

Sanofi And Columbia in Diabetes Collaboration

March 24, 2011 12:12 pm | News | Comments

Sanofi-Aventis SA said it will collaborate with Columbia University Medical Center to research diabetes treatments. The agreement gives Sanofi-Aventis an option to license and develop existing patents and results that may arise from the research.

TOPICS:

Levemir Safe, Effective in Small Children

March 24, 2011 12:06 pm | News | Comments

New clinical trial data show that Levemir, Novo Nordisk’s basal insulin analogue is just as effective for two to five year-old children with type 1 diabetes as human basal insulin, but is associated with lower hypoglycaemic risk.

TOPICS:

Elvitegravir Meets Primary Endpoint

March 24, 2011 12:02 pm | News | Comments

Gilead Sciences, Inc. announced that the Phase 3 clinical trial of its investigational antiretroviral agent elvitegravir, a novel oral integrase inhibitor being evaluated for the treatment of HIV-1 infection in treatment-experienced patients, met its primary objective.

TOPICS:

Mouse Cancer Genome Unveils Genetic Errors in Human Cancers

March 24, 2011 11:57 am | News | Comments

Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse—a mouse.

TOPICS:

First Look at Full Multiple Myeloma Genome

March 24, 2011 11:54 am | News | Comments

Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights.

TOPICS:
Advertisement

New Pill Prevents Type 2 Diabetes

March 24, 2011 11:50 am | News | Comments

A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease

TOPICS:

Two New Targets for Melanoma Therapies

March 24, 2011 11:48 am | News | Comments

The latest clues suggesting potential new ways to treat melanoma come from an unlikely source: fish. Zebrafish don't get sunburns, but they can get skin cancer – at least those fish that have been engineered to model the often deadly human cancer.

TOPICS:

Almac And Exco Working Together

March 24, 2011 11:41 am | News | Comments

The Almac Group and Exco InTouch announced that Almac’s Clinical Technologies business unit has formed a patient management alliance with Exco InTouch, an innovative firm specializing in patient recruitment, retention, compliance and ePRO services.

TOPICS:

ProImmune Receives GLP Certification

March 24, 2011 11:37 am | News | Comments

ProImmune Ltd. announced that it has been accepted into the UK GLP compliance monitoring program by the Medicines & Healthcare products Regulatory Agency formally confirming ProImmune’s compliance with GLP.

TOPICS:

Peptide Workstation

March 24, 2011 7:58 am | Product Releases | Comments

Biotage, a supplier of tools and technology for medicinal, analytical, and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis.

TOPICS:

qPCR Assays

March 24, 2011 7:56 am | Product Releases | Comments

Integrated DNA Technologies (IDT) now offers PrimeTime Pre-designed qPCR Assays which are guaranteed to work for human, mouse, and rat transcriptomes.

TOPICS:

Diaphragm Pumps

March 24, 2011 7:52 am | Drug Discovery & Development | Product Releases | Comments

KNF LABOPORT Filtration Series diaphragm pumps provide ideal solutions for a wide range of applications in the lab, including flask filtration, vacuum blotting, vacuum manifold, and vacuum desiccation.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading